UNITED STATES OF AMERICA v. TEVA PHARMACEUTICALS USA, INC. et al

  1. August 14, 2023

    Teva Scores FCA Trial Delay, Kickback Law Appeal At 1st Circ.

    Teva Pharmaceuticals won a major reprieve Monday when a Massachusetts federal judge delayed an impending False Claims Act trial threatening $10 billion in liability and permitted the drugmaker to pursue First Circuit review of a hotly contested FCA issue that has opened a clear circuit split.

  2. July 26, 2023

    Fearing $10B FCA Loss, Teva Seizes On Kickback Circ. Split

    The U.S. Department of Justice will put Teva Pharmaceuticals in grave danger by pursuing more than $10 billion at an impending False Claims Act trial, amplifying the need for immediate First Circuit review of a question on kickbacks that has cleaved other appellate courts, the drugmaker said Wednesday.

  3. July 17, 2023

    Damages Ruling Ups Stakes In FCA Kickback Case Against Teva

    The government won a pretrial ruling in a False Claim Act case Monday in Massachusetts federal court against Teva Pharmaceuticals that the company has said could expose it to nearly $12 billion in damages for allegedly paying kickbacks to Medicare recipients through patient assistance groups.

  4. July 05, 2023

    FCA Defense Bar Tries Flipping Script On High Court Ruling

    After the U.S. Supreme Court recently fortified barriers to escaping False Claims Act suits, defense counsel have started trying to turn the stumbling blocks into stepping stones, insisting the justices actually made matters harder for FCA plaintiffs alleging fraud and retaliation.

  5. May 25, 2023

    Teva Says Feds Can't Bolster FCA Suit With Advisory Rulings

    Teva Pharmaceuticals USA Inc. asked a federal judge to reject the government's "bald attempt" to get what the company called unconstitutional advisory opinions strengthening a False Claims Act case over alleged kickbacks to Medicare patients.

  6. April 25, 2023

    Teva Seeks Escape From Feds' MS Drug Kickback Suit

    Teva Pharmaceuticals has said it shouldn't have to face a suit from the federal government alleging the company funneled illegal kickbacks to Medicare patients, arguing the government can't prove an essential element of its case.

  7. January 26, 2023

    Teva Can't Get HHS Docs For Kickback Defense

    Teva Pharmaceuticals can't obtain a large volume of documents relating to two nonprofits that the government alleges it used to funnel illegal kickbacks to Medicare patients, a Massachusetts federal judge has said.

  8. October 07, 2022

    Mediating Teva Kickback Case 'Futile At Present,' Feds Say

    Prosecutors pursuing a Medicare kickbacks case against Teva Pharmaceuticals told a Massachusetts federal judge that holding mediation would be "futile at present," opposing the drug giant's request for formal talks.

  9. September 10, 2021

    Teva Loses Bid To Dodge Most Of Feds' FCA Case

    A Massachusetts federal judge refused to let Teva Pharmaceuticals USA Inc. escape most of a lawsuit claiming it used two copay foundations to funnel illegal kickbacks to Medicare patients using its multiple sclerosis drug, but agreed to slightly trim the case.

  10. November 18, 2020

    Feds Urge Court Not To Ax $300M Teva Kickback Case

    The federal government says Teva Pharmaceuticals USA Inc. shouldn't be able to dodge a suit claiming the company used two copay foundations to funnel illegal kickbacks to Medicare patients using its multiple sclerosis drug, arguing the suit sufficiently lays out a purported "long-running scheme."